Wanming He
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
Papers in
-
- Cancer, Hypoxia, and Metabolism 2
- Cancer, Lipids, and Metabolism 2
- Cancer-related molecular mechanisms research 1
-
- Ferroptosis and cancer prognosis 2
- Co-authors
- Min Shi (9 shared papers)Qiong Huang (8 shared papers)Shuyi Zhang (7 shared papers)Shumin Dong (5 shared papers)Zhaowei Wen (3 shared papers)Xingbin Hu (3 shared papers)Yajing Liu (1 shared paper)Wangjun Liao (5 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Molecular Cancer (2 papers)Expert Opinion on Drug Safety (2 papers)Oncotarget (1 paper)Theranostics (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wanming He
12 papers receiving 1.7k citations
Wanming He's Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 705
- Molecular Biology 925
- Pulmonary and Respiratory Medicine 340
- Oncology 201
- Geriatrics and Gerontology 22
Countries citing papers authored by Wanming He
This map shows the geographic impact of Wanming He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanming He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanming He more than expected).
Fields of papers citing papers by Wanming He
This network shows the impact of papers produced by Wanming He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanming He. The network helps show where Wanming He may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanming He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway Hit paper breakdown → | 2017 | 596 |
| 2 | 2019 | 241 | |
| 3 | 2017 | 240 | |
| 4 | 2018 | 200 | |
| 5 | Fluid shear stress and tumor metastasis. | 2018 | 158 |
| 6 | 2018 | 99 | |
| 7 | 2018 | 91 | |
| 8 | 2016 | 45 | |
| 9 | 2018 | 5 | |
| 10 | 2024 | 2 | |
| 11 | 2025 | 1 | |
| 12 | 2025 | 1 | |
| 13 | 2025 | 0 | |
| 14 | 2025 | 0 |
About Wanming He
Wanming He is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Biomaterials, having authored 14 papers that have together received 1.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (3 papers), Ferroptosis and cancer prognosis (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer, Lipids, and Metabolism (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Cancer-related molecular mechanisms research (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Cancer Research (705 citations), Molecular Biology (925 citations), Pulmonary and Respiratory Medicine (340 citations), Oncology (201 citations) and Geriatrics and Gerontology (22 citations). Wanming He has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Min Shi, Qiong Huang, Shuyi Zhang, Shumin Dong, Zhaowei Wen, Xingbin Hu, Yajing Liu, Wangjun Liao, Bishan Liang and Shihui Hao. Their work appears in journals such as Frontiers in Oncology, Molecular Cancer, Expert Opinion on Drug Safety, Oncotarget and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.